MedicaidPrior AuthMedium impact
Intravenous Iron Products (New)
Humana·IN · Hematology, Nephrology, Internal Medicine +2 more·Medicaid
Effective date
Jan 1, 2026
We identified it
Jun 24, 2026
Summary
Humana Medicaid Indiana is implementing a new prior authorization policy for intravenous iron products (Feraheme, Injectafer, Monoferric) effective January 1, 2026. Prior authorization will be required for patients with iron deficiency anemia who must first fail, have contraindications to, or be intolerant of Infed and Venofer.
Action Required
Before January 1, 2026: Billing team must update prior authorization workflow to require preapproval for Feraheme, Injectafer, and Monoferric for Indiana Medicaid patients. Providers must document diagnosis of iron deficiency anemia and prior therapy failure, contraindication, or intolerance to Infed and Venofer. Claims submitted without prior authorization will be denied.